APA

Gallo-Penn A. M., Shirley P. S., Andrews J. L., Kayda D. B., Pinkstaff A. M., Kaloss M., Tinlin S., Cameron C., Notley C., Hough C., Lillicrap D., Kaleko M. & Connelly S. (19991028). In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. : Human gene therapy.

Chicago

Gallo-Penn A M, Shirley P S, Andrews J L, Kayda D B, Pinkstaff A M, Kaloss M, Tinlin S, Cameron C, Notley C, Hough C, Lillicrap D, Kaleko M and Connelly S. 19991028. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. : Human gene therapy.

Harvard

Gallo-Penn A. M., Shirley P. S., Andrews J. L., Kayda D. B., Pinkstaff A. M., Kaloss M., Tinlin S., Cameron C., Notley C., Hough C., Lillicrap D., Kaleko M. and Connelly S. (19991028). In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. : Human gene therapy.

MLA

Gallo-Penn A M, Shirley P S, Andrews J L, Kayda D B, Pinkstaff A M, Kaloss M, Tinlin S, Cameron C, Notley C, Hough C, Lillicrap D, Kaleko M and Connelly S. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. : Human gene therapy. 19991028.